Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation (CONVINCE)

keskiviikko 16. helmikuuta 2022 päivittänyt: Nicholas Hing Yee Liang, Clinical Research Centre, Malaysia

Effective Public Health Communication to Influence COVID-19 Vaccination Intent and Message Propagation: A Randomized Controlled Experiment

This is a randomised controlled experiment in the form of a web based survey study which randomly exposes participants to different forms of public health messages, after which participants will be assessed on their intent to take up the COVID-19 vaccine, recommend the vaccine, and also willingness to propagate the exposed message.

Tutkimuksen yleiskatsaus

Tila

Valmis

Ehdot

Interventio / Hoito

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

5784

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

  • Malesia
    • Selangor
      • Shah Alam, Selangor, Malesia, 40170
        • Institute for Clinical Research, National Institutes of Health, Malaysia

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Willing and able to give informed consent for participation in the trial
  • Malaysian nationality.
  • Can understand either the English or Malay language.
  • Aged 18 years or above

Exclusion Criteria:

  • Received at least one COVID-19 vaccination dose

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Muut
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Descriptive Norm (70%)

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing that about 70% of Malaysians have expressed acceptance for the COVID-19 vaccine.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Descriptive Norm

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing that the COVID-19 vaccine has been widely tested including with the elderly and people with existing health conditions, while subsequently highlighting that the vaccine was already received by millions worldwide.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Healthcare worker (HCW) recommendation

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content highlights recommendation from Malaysian healthcare workers to get the vaccine, since majority of them has already received it, including the Malaysian Health Director General
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Negative attribute framing

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing the rate of side effects occurring with COVID-19 vaccination in a negative frame.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Positive attribute framing

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing the rate of side effects occurring with COVID-19 vaccination in a positive frame.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Risky choice framing (Safety)

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing a risky choice frame which compares the death rates occurring with COVID-19 vaccination versus contracting the virus itself.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Risky choice framing (Side effects)

Intervention in the form of a message likened to a social media post. Composed of 3 parts:

  1. Opening tag line highlighting the main concern that Malaysians have about the COVID-19 vaccine (safety and side effects)
  2. Message content describing a risky choice frame that compares the incidence rates of blood clots occurring with COVID-19 vaccination versus contracting COVID-19.
  3. Rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Control message
Control message containing only rally slogan: "It's safe and effective!"
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + Descriptive Norm
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + HCW recommendation
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + Negative attribute framing
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + Positive attribute framing
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + Risky choice framing (Safety)
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.
Kokeellinen: Combination message: Descriptive Norm (70%) + Risky choice framing (Side effects)
Participants received 2 messages which were exposed one at a time. Sequence of message appearing randomly rotated.
Käyttäytyminen: Health message exposure
Participants exposed to a health message and requested to read it completely. Subsequently requested to answer post intervention questions that form basis for outcome measures.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in intent to accept the COVID-19 vaccine amongst the Malaysian adult population.
Aikaikkuna: Immediately before and after message exposure during questionnaire administration.
Outcome measure was assessed using a questionnaire answered through a 4 point ordinal scale. Scale ranges from '"Definitely no", "Not sure, but probably no", "Not sure, but probably yes"to Definitely yes".
Immediately before and after message exposure during questionnaire administration.
Change in intent to recommend the COVID-19 vaccine to healthy adults.
Aikaikkuna: Immediately before and after message exposure during questionnaire administration.
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
Immediately before and after message exposure during questionnaire administration.
Change in intent to recommend the COVID-19 vaccine to elderly.
Aikaikkuna: Immediately before and after message exposure during questionnaire administration.
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
Immediately before and after message exposure during questionnaire administration.
Change in intent to recommend the COVID-19 vaccine to people with existing health conditions.
Aikaikkuna: Immediately before and after message exposure during questionnaire administration.
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
Immediately before and after message exposure during questionnaire administration.
Intent to share message on social media platform.
Aikaikkuna: Immediately after message exposure during questionnaire administration.
Outcome measure was assessed using a questionnaire answered through a 5 point ordinal scale.Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
Immediately after message exposure during questionnaire administration.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Moderators of vaccination intent.
Aikaikkuna: Immediately after message exposure during questionnaire administration.
Outcome measure assessed using a series of questions answered through a 5 point ordinal scale. Scale ranges from "Strongly disagree", "Disagree", "Not sure", "Agree", and "Strongly agree".
Immediately after message exposure during questionnaire administration.
Reliability of various information sources about COVID-19.
Aikaikkuna: Immediately after message exposure during questionnaire administration.
Outcome measure assessed using a questionnaire that list out various types of information sources and having participants to rate the reliability for each source using a 5 point ordinal scale. Scale ranges from "Strongly not reliable", "Not reliable, "Not sure", "Reliable", and "Strongly reliable".
Immediately after message exposure during questionnaire administration.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Sponsori

Clinical Research Centre, Malaysia

Yhteistyökumppanit

University of Malaya
London School of Economics and Political Science
Ministry of Health, Malaysia
UNICEF Malaysia
Institute for Health Behavioral Research, Malaysia

Tutkijat

  • Päätutkija: Yee Liang Hing, MSc., Clinical Research Centre, Malaysia

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Torstai 29. huhtikuuta 2021

Ensisijainen valmistuminen (Todellinen)

Maanantai 7. kesäkuuta 2021

Opintojen valmistuminen (Todellinen)

Maanantai 7. kesäkuuta 2021

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 10. helmikuuta 2022

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 16. helmikuuta 2022

Ensimmäinen Lähetetty (Todellinen)

Torstai 17. helmikuuta 2022

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Torstai 17. helmikuuta 2022

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 16. helmikuuta 2022

Viimeksi vahvistettu

Tiistai 1. helmikuuta 2022

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Avainsanat

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • NMRR-21-26-58107

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa